Man Group PLC Immuneering Corp Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Immuneering Corp stock. As of the latest transaction made, Man Group PLC holds 13,778 shares of IMRX stock, worth $26,729. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,778

Holding current value

$26,729

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.03 - $3.21 $14,191 - $44,227	13,778 New	13,778 $34,000
Q1 2023 May 15, 2023	SELL	$3.78 - $10.38 $23,413 - $64,293	-6,194 Reduced 33.72%	12,174 $118,000
Q4 2022 Feb 14, 2023	BUY	$4.09 - $15.0 $75,125 - $275,520	18,368 New	18,368 $89,000

Others Institutions Holding IMRX

# of Institutions

Shares Held

4.78M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

1.07M
Shares

$2.08 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

810K
Shares

$1.57 Million
0.0% of portfolio
Black Rock Inc. New York, NY

533K
Shares

$1.03 Million
0.0% of portfolio
Morgan Stanley New York, NY

449K
Shares

$871,663
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

246K
Shares

$477,763
0.0% of portfolio

View Full List

About Immuneering Corp

Ticker IMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,392,300
Market Cap $51.2M
Description
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...

More about IMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account